EIF3B silencing resulted in the decrease of cell viability and the increase of apoptosis level in osteosarcoma cells, and EIF3B could participate in osteosarcoma cell proliferation by targeting TNFRSF21 (25). This evidence concerns the gene TNFRSF21 and osteosarcoma.